CYCheol-Jung Yang

Cheol-Jung Yang

*This is an algorithmically generated author record based on publicly available information.

Cheol-Jung Yang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Tendon Traction Point Therapy for Medial Knee Pain in an Elite Badminton Player: A Case Report

    by Cheol-Jung Yang, Sin-Hye Park, Taek-Sung Kim, Kook-Hee An, Eun-Ae Kim, Hae-Jung Oh, Jeong-Won Seong

    Medial knee pain in elite athletes is often attributed to structural lesions such as medial meniscus tears; however, imaging findings do not always correspond to the primary pain generator. We report a 20-year-old elite badminton player diagnosed with a partial tear of the medial meniscus posterior horn (MMPH) who presented with severe medial knee pain and was initially recommended for surgical treatment. Detailed clinical evaluation suggested that the patient’s symptoms were more consistent with pes anserinus-related pathology involving the sartorius, gracilis, and semitendinosus (SGS) tendon complex. Under ultrasound guidance, four weekly injections of 5 mL 5% dextrose were administered into the tendon traction points (TTP) of the sartorius, gracilis, and semitendinosus muscles. Pain scores markedly improved from 8 to 1 on the Visual Analog Scale (VAS), with rapid recovery of function and full return to competition without surgical intervention. At two-month follow-up, the athlete reported minimal residual discomfort without any functional limitations. This case highlights the importance of identifying the true pain generator in medical knee pain and demonstrates that TTP injection therapy is a safe, steroid-free, and minimally invasive non-surgical alternative, particularly in athletes where rapid return to play is critical.

  • Open Access

    A novel non-steroidal treatment approach for moderate Atopic dermatitis in a 13-month-old infant using SNEPI: a case report

    by Cheol-Jung Yang, Sin-Hye Park, Daewook Lee, Sin-Hwe Kim, Minha Kim, Je-Hun Lee, So-Jung Kim, Taek-Sung Kim, Kook-Hee An, Eun-Ae Kim, et al.

    Atopic dermatitis (AD) is a chronic inflammatory skin condition with increasing prevalence in infancy. Standard treatments rely heavily on topical corticosteroids, but concerns about long-term side effects and limited efficacy in some cases highlight the need for alternative therapeutic strategies. We present a 13-month-old male with moderate AD refractory to moisturizers and hydrocortisone ointments. Sympathetic Nerve Entrapment Point Injection (SNEPI) was administered bilaterally at the T7 paraspinal level using 1 mL of normal saline once weekly for three sessions. Clinical outcomes were monitored during treatment and over a six-year follow-up period. Pruritus resolved and sleep normalized after the first treatment. By the third session, complete remission of skin lesions was achieved without corticosteroid use, with no recurrence observed during four weeks of follow-up. During a six-year follow-up, the child maintained stable skin with only occasional mild pruritus, suggesting sustained therapeutic benefit. This case demonstrates the potential of SNEPI as a safe, effective, and steroid-free neuromodulatory treatment for pediatric AD, supporting the role of autonomic modulation in inflammatory skin disorders. Further clinical studies are warranted to evaluate the broader applicability of SNEPI in pediatric dermatology.

  • Open Access

    Effective Treatment of Acute Wrist Pain in a Competitive Weightlifter Using Tendon Traction Point-Focused Dextrose Injections: A Case Report

    by Cheol-Jung Yang, Sin-Hye Park, Je Hun Lee, Taek-Sung Kim, Jeong-Won Seong

    Wrist pain is common among athletes, particularly weightlifters, who perform repetitive high-intensity movements like the snatch and clean and jerk. Conventional treatments, including NSAIDs, corticosteroids, and physical therapy, often provide only symptomatic relief. This case report highlights effective management of acute wrist pain in a competitive weightlifter using Tendon Traction Point (TTP)-focused dextrose injections. A 23-year-old weightlifter presented with wrist pain persisting for two weeks despite prior treatments. Tenosynovitis of the extensor digitorum communis (EDC) and extensor carpi radialis brevis (ECRB) tendons was confirmed by ultrasound. After four injections of 5% dextrose into identified TTPs, the patient’s Visual Analog Scale (VAS) score improved from 7 to 1. The treatment relieved pain and enabled the athlete to return to competition. This report demonstrates that TTP-focused dextrose injections offer a rapid, effective, and non-invasive solution for athletes with tendon overuse pain, presenting a promising alternative to traditional therapies and supporting functional recovery.


  • Open Access

    A Novel Therapeutic Approach Targeting Spinal Accessory and Dorsal Scapular Nerves for the Relief of Posterior Neck, Trapezius, and Interscapular Pain

    by Sin-Hye Park, Sin-Hwe Kim, Minha Kim, Jong Burm Jung, Kwangwoon Choi, Daewook Lee, Je-Hun Lee, Jeong Won Seong, Cheol-Jung Yang

    Background/Objectives: Posterior neck, trapezius, and interscapular pain, exacerbated by poor posture such as forward head and rounded shoulders, is common. In this study, we aimed to assess the clinical outcomes of isotonic saline injections at nerve entrapment points (NEPs) within the sternocleidomastoid (SCM) and scalenus medius (SM) muscles for alleviating spinal accessory nerve (SAN) and dorsal scapular nerve (DSN) compression in patients suffering from posterior neck, trapezius, and interscapular pain. Methods: In this retrospective study, 68 patients were included, with 34 receiving isotonic saline injections and 34 undergoing Extracorporeal Shock Wave Therapy (ESWT) as a control. The clinical outcomes were evaluated using the Visual Analog Scale (VAS) and Percent Pain Intensity Difference (PPID) before and after therapy. The effectiveness of isotonic saline injections targeting NEPs in the SCM and SM muscles in relieving pain associated with SAN and DSN entrapment was assessed. Results: Both treatments significantly reduced VAS and PPID scores, with injection therapy showing a larger treatment effect size (Cohen’s d: 3.521 for VAS and 3.521 for PPID) compared to ESWT (Cohen’s d: 1.379 for VAS and 1.710 for PPID). The mean clinically important difference observed for VAS was 4.2, exceeding the expected value of 2.6, indicating a substantial improvement in pain and patient quality of life. Conclusions: Isotonic saline injections at the NEPs of SAN and DSN within the SCM and SM muscles might potentially reduce posterior neck, trapezius, and interscapular pain associated with possible nerve entrapment, without causing complications. Further research is needed to validate these findings in larger, controlled trials.


  • Open Access

    Effectiveness of Novel Sympathetic Nerve Entrapment Point Injections for Chronic Migraine: A Pilot Study

    by Jeong Won Seong, Yuntae Kim, Dong Rak Kwon, Cheol-Jung Yang, Levent Özçakar

    No studies to date have investigated the ability of sympathetic nerve entrapment point saline (SNEP) injections to achieve long-term pain relief in patients with migraine. Therefore, this study aimed to investigate the safety and long-term efficacy of repeat splenius capitis (SC) SNEP injections in patients with migraine (with/without tension-type headache). This retrospective, single-arm study included 12 patients with migraine. Isotonic saline was injected into their SC approximately six times for 3 months. Headache frequency, duration (hour/week), intensity (using the visual analog scale), and quality of life (using the Headache Impact Test-6) were assessed during the follow-up visits for up to 24 months after the first injection. Changes before and after treatment were assessed using repeated-measures analysis of variance. Significant reductions in headache frequency, duration, and intensity were observed at all assessment points after SNEP injections when compared with the baseline values (p < 0.05), while the patients’ headache-related quality of life also improved. Treatment was continued for up to 3 months to maintain these improvements, and no worsening of status or adverse effects were observed in any of the patients over the following 24 months. Our results show that SNEP injections may offer persistent, substantial, and clinically relevant benefits in patients with migraine.


  • Open Access

    Novel Therapeutic Approach for Extensor Digiti Minimi Tendon Traction in Chronic Ulnar-Sided Wrist Pain Diagnosed as Triangular Fibrocartilage Complex Injury: A Case Report

    by Cheol-Jung Yang, Jeong Won Seong

    Cheol-Jung Yang, Jeong Won Seong. KJSM 2023;41:250-5. https://doi.org/10.5763/kjsm.2023.41.4.250


  • Open Access

    Novel Therapeutic Approach for Tibial Nerve Entrapment in Chronic Heel Pain Diagnosed as Plantar Fasciitis: A Case Report

    by Cheol-Jung Yang, Jeong Won Seong, Dongrak Kwon, Yuntae Kim

    Cheol-Jung Yang, Jeong Won Seong, Dongrak Kwon, Yuntae Kim. KJSM 2023;41:241-5. https://doi.org/10.5763/kjsm.2023.41.4.241


  • Correction to: Correlation between the presence of herniation pit and femoroacetabular impingement: a systematic review and meta-analysis

    by Chul-Ho Kim, Sangwon Han, Cheol-Jung Yang, Jun Ho Kim

    Authors would like to correct the errors in figure 4 legend.

  • Correlation between the presence of herniation pit and femoroacetabular impingement: a systematic review and meta-analysis

    by Chul-Ho Kim, Sangwon Han, Cheol-Jung Yang, Jun Ho Kim

    Purpose The purpose of this systematic review and meta-analysis was to evaluate the correlation between the incidence of herniation pits (HPs) and femoroacetabular impingement (FAI)-related morphologies. Methods A systematic search of the MEDLINE, EMBASE, and Cochrane Library databases was performed for studies evaluating the relationship between the incidence of HPs and FAI-related morphologies published up to August 16, 2019. Subgroup analyses were also performed to determine the differences in the relationship between the presence/absence of hip symptoms and cam-/pincer-type FAI. Results Seven studies involving 7950 hips were included. The pooled odds ratio (OR) for the incidence of HPs in the presence of an FAI-related morphology was 1.64 (95% confidence interval [CI] = 1.09–2.46; P = 0.02). In the subgroup analyses, the ORs for the incidence of HPs in the symptomatic and asymptomatic hips were 1.00 (95% CI 0.40–2.51; P = 1.00) and 1.59 (95% CI 1.42–1.77; P < 0.0001), respectively; the ORs for the incidence of HPs in the cam- and pincer-type FAI were 1.61 (95% CI 1.43–1.81; P < 0.0001) and 1.42 (95% CI 0.77–2.61; P = n.s.), respectively. Conclusions The incidence of HPs has a significant relationship with FAI-related morphology, especially in asymptomatic patients and those with cam-type FAI morphology. Level of evidence III.